Teladoc Stock Plummets Following Disappointing Q2 Earnings
Teladoc's stock experienced a significant drop after the company reported disappointing Q2 earnings results.
6 stories found
Teladoc's stock experienced a significant drop after the company reported disappointing Q2 earnings results.
The earnings transcript for Teladoc (TDOC) for the first quarter of 2026 has been released, detailing the company's financial performance and operational insights.

Video game retailer GameStop is reportedly preparing an offer to acquire e-commerce giant eBay, according to reports from The Wall Street Journal. This potential move signals GameStop's ambition for greater relevance in the market.
Bank of America (BofA) and Goldman Sachs have both reduced their price targets for Teladoc (TDOC), reflecting revised expectations for the telehealth provider.
Financial analysts are presenting varied perspectives on Pfizer (PFE) stock, with some expressing bullish sentiment and recommending it as a strong investment. Others, like Morgan Stanley, maintain an "Equal Weight" rating due to patent concerns, while still considering it among the best medical stocks.
Bank of America has lowered its price target for Teladoc (TDOC), citing peer multiple compression and soft Sensor Tower trends as key factors.